{"database": "openregs", "table": "federal_register", "rows": [["2017-27156", "Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease; Draft Guidance for Industry; Availability", "Notice", "The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled \"Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease.\" The purpose of this guidance is to describe the FDA's current recommendations on how to group patients with different molecular alterations for eligibility in clinical trials; and general approaches to evaluating the benefits and risks of targeted therapeutics within a clinically defined disease where some molecular alterations may occur at low frequencies.", "2017-12-18", 2017, 12, "https://www.federalregister.gov/documents/2017/12/18/2017-27156/developing-targeted-therapies-in-low-frequency-molecular-subsets-of-a-disease-draft-guidance-for", "https://www.govinfo.gov/content/pkg/FR-2017-12-18/pdf/2017-27156.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled \"Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease.\" The purpose of this guidance is to describe the...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2017-27156"], "units": {}, "query_ms": 0.8511021733283997, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}